Cornercap Investment Counsel’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-94,783
Closed -$175K 698
2023
Q1
$175K Hold
94,783
0.03% 511
2022
Q4
$105K Hold
94,783
0.02% 534
2022
Q3
$222K Buy
94,783
+52,718
+125% +$123K 0.04% 483
2022
Q2
$127K Buy
+42,065
New +$127K 0.02% 520